Lexeo Therapeutics Inc (LXEO)
$3.14 +2.61% Close Oct 30, 2026 Live
Lexeo Therapeutics stock today
Lexeo Therapeutics closed at $3.14 on October 30, 2026, up 2.61% on the day. Over the past year it returned -66.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $247 million.
$2.50$5.00$7.50$10.00
NovJan 2026MarMayJulSep
| Period | LXEO | S&P 500 (SPY) |
|---|---|---|
| 1 month | -7.1% | -0.9% |
| 3 months | -27.8% | +2.1% |
| Year to date | -68.4% | +11.7% |
| 1 year | -66.7% | +12.4% |
Key statistics
- Market value
- $247M
- 52-week range
- $2.63 to $10.63
- Next report
- Nov 4, 2026 (estimated)
About Lexeo Therapeutics
Biopharmaceutical company developing gene therapy treatments for inherited genetic disorders.
Sector: Health Care
More on Lexeo Therapeutics
- Returns: what $1,000 became$1,000 one year ago is $332.98 today
No forecast, no recommendation. This page describes Lexeo Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.